Masoud Najafi (M Najafi)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Topics

Top Venues

Current radiopharmaceuticals

Clinical and experimental pharmacology & physiology

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Rasool Azmoonfar, Fatemeh Mirzaei, Masoud Najafi, Maryam Varkeshi, Karim Ghazikhanlousani, Sara Momeni, Korosh Saber
Radiation-induced Testicular Damage in Mice: Protective Effects of Apigenin Revealed by Histopathological Evaluation. Current radiopharmaceuticals (2024)
Rasool Azmoonfar, Fatemeh Mirzaei, Masoud Najafi, Maryam Varkeshi, Karim Ghazikhanlousani, Sara Momeni, Korosh Saber
Radiation-induced Testicular Damage in Mice: Protective Effects of Apigenin Revealed by Histopathological Evaluation. Current radiopharmaceuticals (2024)
Rasool Azmoonfar, Fatemeh Mirzaei, Masoud Najafi, Maryam Varkeshi, Karim Ghazikhanlousani, Sara Momeni, Korosh Saber
Radiation-induced Testicular Damage in Mice: Protective Effects of Apigenin Revealed by Histopathological Evaluation. Current radiopharmaceuticals 17 (3) (2024)
Rasool Azmoonfar, Fatemeh Mirzaei, Masoud Najafi, Maryam Varkeshi, Karim Ghazikhanlousani, Sara Momeni, Korosh Saber
Radiation-induced Testicular Damage in Mice: Protective Effects of Apigenin Revealed by Histopathological Evaluation. Current radiopharmaceuticals 17 (3) (2024)
Ali Hamid AbdulHussein, Muataz Mohammed Al-Taee, Zahra Abdul Radih, Dhuha Salman Aljuboory, Zainab Qasim Mohammed, Tabarak Sami Hashesh, Yassine Riadi, Salema K Hadrawi, Masoud Najafi
Mechanisms of cancer cell death induction by triptolide. BioFactors (Oxford, England) (2023)
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, Nima Rastegar-Pouyani, Kave Moloudi, Ehsan Khodamoradi, Shahram Taeb, Masoud Najafi
Immunoregulation by resveratrol; implications for normal tissue protection and tumor suppression. Clinical and experimental pharmacology & physiology (2023)
Kave Moloudi, Ali Khani, Masoud Najafi, Rasool Azmoonfar, Mahdi Azizy, Houra Nekounam, Mahsa Sobhani, Sophie Laurent, Reza Faridi-Majidi
Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (2023)
Armineh Rezagholi Lalani, Fatemeh Fakhari, Shakila Radgoudarzi, Nima Rastegar-Pouyani, Kave Moloudi, Ehsan Khodamoradi, Shahram Taeb, Masoud Najafi
Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression. Clinical and experimental pharmacology & physiology (2023)
Xiao-Yu Wu, Wen-Wen Xu, Xiang-Kun Huan, Guan-Nan Wu, Gang Li, Yu-Hong Zhou, Masoud Najafi
Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Molecular and cellular biochemistry (2022)
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, Mohammad Javed Ansari, Mohammed Abed Jawad, Abduladheem Turki Jalil, Nima Rastegar-Pouyani, Emad Jafarzadeh, Shahram Taeb, Masoud Najafi
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms. Clinical and experimental pharmacology & physiology (2022)
Jun Huang, Zaoshang Chang, Quzhe Lu, Xuedong Chen, Masoud Najafi
Nobiletin as an inducer of programmed cell death in cancer: a review. Apoptosis : an international journal on programmed cell death 27 (5-6) (2022)
Milad Ashrafizadeh, Masoud Najafi, Nasim Kavyiani, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian
Anti-Inflammatory Activity of Melatonin: a Focus on the Role of NLRP3 Inflammasome. Inflammation 44 (4) (2021)
Run Yang, Changming Tan, Masoud Najafi
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents. Inflammopharmacology (2021)
Xiao Fu, Yingni He, Mu Li, Zezhi Huang, Masoud Najafi
Targeting of the tumor microenvironment by curcumin. BioFactors (Oxford, England) 47 (6) (2021)
Xiao Fu, Mu Li, Cuilian Tang, Zezhi Huang, Masoud Najafi
Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis : an international journal on programmed cell death 26 (11-12) (2021)
Zihong Wu, Caidie Zhang, Masoud Najafi
Targeting of the tumor immune microenvironment by metformin. Journal of cell communication and signaling (2021)
Chong Yu, Bo Yang, Masoud Najafi
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic & clinical pharmacology & toxicology 129 (6) (2021)
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Sedigheh Saberifar, Saeed Salami, Kiavash Hushmandi, Masoud Najafi
Recent advances and future directions in anti-tumor activity of cryptotanshinone: A mechanistic review. Phytotherapy research : PTR 35 (1) (2020)
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Vahideh Zarrin, Ebrahim Rahmani Moghadam, Amirhossein Zabolian, Shima Mohammadi, Kiavash Hushmandi, Yashar Gharehaghajlou, Pooyan Makvandi, Masoud Najafi, Reza Mohammadinejad
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects. Biology 9 (6) (2020)
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Ebrahim Rahmani Moghadam, Mehdi Raei, Mahshad Kalantari, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi, Franklin R Tay, Giuseppe Perale
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS combinatorial science 22 (12) (2020)
Milad Ashrafizadeh, Kiavash Hushmandi, Mehrdad Hashemi, Mohammad Esmaeil Akbari, Peter Kubatka, Mehdi Raei, Lenka Koklesova, Md Shahinozzaman, Reza Mohammadinejad, Masoud Najafi, Gautam Sethi, Alan Prem Kumar, Ali Zarrabi
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules 10 (8) (2020)
Milad Ashrafizadeh, Masoud Najafi, Hui Li Ang, Ebrahim Rahmani Moghadam, Mahmood Khaksary Mahabady, Amirhossein Zabolian, Leila Jafaripour, Atefe Kazemzade Bejandi, Kiavash Hushmandi, Hossein Saleki, Ali Zarrabi, Alan Prem Kumar
PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines 8 (8) (2020)
Milad Ashrafizadeh, Masoud Najafi, Giuseppe Perale, Ali Zarrabi, Tahereh Farkhondeh, Saeed Samarghandian
Versatile role of curcumin and its derivatives in lung cancer therapy. Journal of cellular physiology 235 (12) (2020)
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian
Flaming the fight against cancer cells: the role of microRNA-93. Cancer cell international 20 (2020)
Ehsan Khodamoradi, Mojtaba Hoseini-Ghahfarokhi, Peyman Amini, Elahe Motevaseli, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Masoud Najafi, Bagher Farhood
Targets for protection and mitigation of radiation injury. Cellular and molecular life sciences : CMLS 77 (16) (2020)
Lenka Koklesova, Alena Liskova, Marek Samec, Constanze Buhrmann, Samson Mathews Samuel, Elizabeth Varghese, Milad Ashrafizadeh, Masoud Najafi, Mehdi Shakibaei, Dietrich Busselberg, Frank A Giordano, Olga Golubnitschaja, Peter Kubatka
Carotenoids in Cancer Apoptosis-The Road from Bench to Bedside and Back. Cancers 12 (9) (2020)
Milad Ashrafizadeh, Masoud Najafi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Negin Sharifi, Kiavash Hushmandi, Ali Zarrabi, Yeong Shik Kim
Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines 8 (8) (2020)
Lenka Koklesova, Alena Liskova, Marek Samec, Kevin Zhai, Mariam Abotaleb, Milad Ashrafizadeh, Aranka Brockmueller, Mehdi Shakibaei, Kamil Biringer, Ondrej Bugos, Masoud Najafi, Olga Golubnitschaja, Dietrich Busselberg, Peter Kubatka
Carotenoids in Cancer Metastasis-Status Quo and Outlook. Biomolecules 10 (12) (2020)
Milad Ashrafizadeh, Ali Zarrabi, Masoud Najafi, Saeed Samarghandian, Reza Mohammadinejad, Yeong Shik Kim
Resveratrol targeting tau proteins, amyloid-beta aggregations, and their adverse effects: An updated review. Phytotherapy research : PTR 34 (11) (2020)
Milad Ashrafizadeh, Hui Li Ang, Ebrahim Rahmani Moghadam, Shima Mohammadi, Vahideh Zarrin, Kiavash Hushmandi, Saeed Samarghandian, Ali Zarrabi, Masoud Najafi, Reza Mohammadinejad, Alan Prem Kumar
MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 10 (7) (2020)
Peyman Amini, Milad Ashrafizadeh, Elahe Motevaseli, Masoud Najafi, Alireza Shirazi
Mitigation of radiation-induced hematopoietic system injury by melatonin. Environmental toxicology 35 (8) (2020)
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Vahideh Zarrin, Sharareh Hosseinzadeh Kashani, Saied Bokaie, Masoud Najafi, Shima Tavakol, Reza Mohammadinejad, Noushin Nabavi, Chia-Ling Hsieh, Atefeh Zarepour, Ehsan Nazarzadeh Zare, Ali Zarrabi, Giuseppe Perale
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer. Bioengineering (Basel, Switzerland) 7 (3) (2020)
Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Masoud Najafi, Elahe Motevaseli, Farzad Nouruzi, Dheyauldeen Shabeeb, Ahmed Eleojo Musa
Selenium-L-methionine modulates radiation injury and Duox1 and Duox2 upregulation in rat's heart tissues. Journal of cardiovascular and thoracic research 11 (2) (2019)
Bagher Farhood, Keywan Mortezaee, Elahe Motevaseli, Hanifeh Mirtavoos-Mahyari, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Nafiseh Sadat Sanikhani, Masoud Najafi, Amirhossein Ahmadi
Selenium as an adjuvant for modification of radiation response. Journal of cellular biochemistry 120 (11) (2019)
Hamed Barabadi, Masoud Najafi, Hadi Samadian, Asaad Azarnezhad, Hossein Vahidi, Mohammad Ali Mahjoub, Mahbobeh Koohiyan, Amirhossein Ahmadi
A Systematic Review of the Genotoxicity and Antigenotoxicity of Biologically Synthesized Metallic Nanomaterials: Are Green Nanoparticles Safe Enough for Clinical Marketing? Medicina (Kaunas, Lithuania) 55 (8) (2019)
R Yahyapour, E Motevaseli, A Rezaeyan, H Abdollahi, B Farhood, M Cheki, S Rezapoor, D Shabeeb, A E Musa, Masoud Najafi, V Villa
Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (8) (2018)
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, Neda Khanlarkhani, Ensieh Salehi, Maryam Shabani Nashtaei, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Hengameh Fallah, Masoud Najafi
Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation. Journal of cell communication and signaling 13 (1) (2018)
B Farhood, N H Goradel, K Mortezaee, N Khanlarkhani, E Salehi, M S Nashtaei, H Mirtavoos-Mahyari, E Motevaseli, D Shabeeb, A E Musa, Masoud Najafi
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (3) (2018)
Masoud Najafi, Elahe Motevaseli, Alireza Shirazi, Ghazale Geraily, Abolhasan Rezaeyan, Farzad Norouzi, Saeed Rezapoor, Hamid Abdollahi
Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications. International journal of radiation biology 94 (4) (2018)
Rasoul Azmoonfar, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli, Mohsen Cheki, Rasoul Yahyapour, Bagher Farhood, Farzad Nouruzi, Ehsan Khodamoradi, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Masoud Najafi
Metformin Protects Against Radiation-Induced Pneumonitis and Fibrosis and Attenuates Upregulation of Dual Oxidase Genes Expression. Advanced pharmaceutical bulletin 8 (4) (2018)